Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients

Follow Drugslib on

By Andria Park Huynh HealthDay Reporter

Medically reviewed by Judith Stewart, BPharm. Last updated on May 29, 2026.

via HealthDay

FRIDAY, May 29, 2026 — A Kenyan court has reportedly shut down a plan set in motion by the Trump administration to quarantine Ebola-exposed Americans in Kenya.

A response to an outbreak in the Democratic Republic of Congo (DRC), the plan was to quarantine exposed or infected U.S. citizens at a makeshift field hospital in Kenya. The move concerned health experts, who warned that care overseas would be inferior to that available in U.S. specialized units.

The Kenyan court suspended the plan the day U.S. officials intended to open the facility, citing a threat to the lives of the Kenyan people, according to The Washington Post.

The facility was built by the U.S. military at Laikipia Air Base, about 125 miles from Nairobi, Kenya’s capital. It would have been staffed by U.S. Public Health Service officers.

While Kenya agreed to the plan for the field hospital, it sparked widespread public opposition and was challenged in court by Katiba Institute, a constitutional rights advocacy group, The Post reported.

The group petitioned the court to bar individuals who are exposed to or infected with Ebola from entering the nation. It also urged the court to have the Kenyan Health Ministry present a contingency plan for its Ebola preparedness and to disclose its terms, The Post said.

“At its core, the case is about preserving constitutional accountability, protecting public health and ensuring that no government may place expediency above the lives and safety of the people of Kenya,” the Katiba Institute posted on X.

In response, a judge ruled Friday that no one from the Ebola-affected regions is allowed to enter Kenya and that the quarantine facility will not open prior to a court hearing scheduled for June 2.

Besides sparking a public outcry, the plan also raised ethical questions about the Trump administration’s refusal to let Americans exposed to Ebola receive treatment back home.

A senior administration official said Thursday that the field hospital was designed to offer respiratory support and hydration on site. Americans would be sent to specialized facilities in Europe if more advanced care were needed. The official said transporting Americans to those facilities would be safer and faster than putting them on long flights back to the United States, according to The Post.

There is no currently approved vaccine or therapeutic for the Bundibugyo virus, the strain of Ebola that is at the center of the outbreak in the DRC.

Patients at the proposed Kenyan facility who become ill before evacuating would be treated with monoclonal antibodies and a broad-spectrum antiviral called remdesivir. While not approved to treat Ebola, it is commonly used off-label.

Ebola is believed to have claimed nearly 250 lives and sickened more than 1,000 in the DRC and Uganda, according to data from the U.S. Centers for Disease Control (CDC). To date, there are no Ebola cases associated with the outbreak in the United States, and the risk to the general public remains low, says the CDC’s website.

Sources

  • The Washington Post, May 29, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-05-30 03:14

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords